Deep cleaning (PMPR) plus chlorhexidine mouthwash for gums and blood vessel health
Official title: The Effect of Professional Mechanical Plaque Removal (PMPR) and Chlorhexidine Mouthwash on Salivary and Acquired Enamel Pellicle (AEP) Proteins and Vascular Function and Inflammation in People With Periodontal Disease
Run by University of Portsmouth · NCT07311512 · Data updated 2026-11-12
This study will test whether professional deep cleaning with or without a 0.2% chlorhexidine mouthwash changes saliva proteins, mouth bacteria, and blood vessel function in adults with gingivitis or early periodontitis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 75 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of Portsmouth Academic / other |
| Locations | 1 site (Portsmouth, Hampshire) |
| Status | Recruiting |
| Started | January 23, 2026 |
| Main results expected | July 1, 2028 |
| Study ends | July 1, 2028 |
| Registry record updated | March 25, 2026 |
| Trial ID | NCT07311512 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with gingivitis or early (stage 1–2) periodontitis who have at least 12 natural teeth, have not had PMPR in the past 6 months, and have not taken antibiotics in the past 3 months are the intended participants.
✕Probably not a fit
People with advanced periodontitis (stage 3–4), those on regular systemic medications (including for hypertension or diabetes), pregnant or breastfeeding individuals, recent antibiotic users, or those wearing orthodontic appliances are unlikely to be eligible or to gain direct benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Thirty adults with clinically confirmed gingivitis or stage 1–2 periodontitis will receive standard professional mechanical plaque removal (PMPR). After PMPR, participants will use either 0.2% chlorhexidine mouthwash or a placebo mouthwash and be followed for changes in salivary and acquired enamel pellicle proteins, oral microbiome composition, and nitrate-reducing bacteria activity. Vascular outcomes such as endothelial function and arterial stiffness will be measured alongside oral endpoints to explore oral-systemic links. The study compares pre- and post-treatment measures to see if adjunctive chlorhexidine alters beneficial oral bacteria or vascular health.
Why it matters
Potential benefit: If successful, the results could clarify whether adding chlorhexidine to standard deep cleaning protects or harms oral nitrate-reducing bacteria and therefore help guide safer periodontal care that supports blood vessel health.
How similar studies have gone: Prior studies show chlorhexidine reliably reduces plaque but can lower oral nitrate-reducing bacteria and small trials have linked CHX use to short-term blood pressure changes, so elements are supported though the direct vascular consequences remain not fully settled.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants must have a minimum of 2 natural teeth in each sextant (at least 12 teeth overall). * Individuals with clinically diagnosed gingivitis and/or early periodontitis (stage 1 and 2) * Must not have undergone periodontal maintenance therapy (PMPR) within the last 6 months. * Must not currently be wearing orthodontic appliances, due to their effect on oral microbiota and plaque composition. * Must not be using removable orthodontic appliances, as they increase plaque accumulation. * Must not have taken any antibiotic treatments within the last 3 months. * Must be able to provide written informed consent. * Individuals with dental erosion or caries will still be included but matched during the baseline visit. Exclusion Criteria: * Individuals under regular medication within one month of the study start date for any medical condition (such as hypertension and/or diabetes) * Pregnant or breastfeeding individuals. * Individuals requiring an interpreter or who are non-English speakers. * Individuals unable to provide written informed consent. * Individuals participating in another ongoing clinical study (other than observational studies) within 3 months prior to or during this study. * Individuals who have used mouthwash or tongue scrapers in the last 6 weeks. * Individuals who consume 20 or more cigarettes per day. * Individuals who consume more than 5 alcoholic drinks per day.
Where it's running
-
University of Portsmouth
Portsmouth, Hampshire, United Kingdom Recruiting
Study contacts
- Study coordinator: Mahdi Mutahar, PhD
- Email: mahdi.mutahar@port.ac.uk
- Phone: 02392845528
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heat therapy during reduced activity to protect heart and muscle health
A randomized trial tests whether daily Finnish dry sauna help preserves cardiovascular and muscle health when daily activity is reduced for seven days in healthy adults.
-
Platelets and plasma lipids as markers and targets in thrombosis
This study tests whether two lipid emulsion formulations change platelet clumping in healthy volunteers age 40 and up who do not have heart disease.
-
Compare two ventilator modes in adults with cardiac ICU needs and invasive ventilation
This pilot tests whether volume-controlled versus pressure-controlled ventilation can be safely used in adults with heart disease and respiratory failure who need invasive ventilation.
-
Carotid ultrasound to guide prevention of heart disease in inflammatory rheumatic diseases
In people with inflammatory rheumatic diseases like RA, PsA, AxSpA, or SLE who are at modest cardiovascular risk, a carotid ultrasound test is used to see if they should start stronger lipid-lowering therapy to prevent heart problems.
-
FES-Cycling With Blood Flow Restriction for SCI/D Patients
This study tests safe and feasible use of functional electrical stimulation cycling with blood flow restriction in adults with spinal cord injury to see if it can help reduce cardiometabolic risk.
-
Endothelial progenitor cell dysfunction and inflammation in heart and blood vessel problems of type 2 diabetes
This project will test whether endothelial progenitor cells from adults with type 2 diabetes — with or without cardiovascular complications — have signaling and inflammation-related defects and whether boosting eNOS in those cells improves their repair function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.